Risk factors of significant intraoperative blood loss in unilateral expansive open-door cervical laminoplasty for cervical compressive myelopathy: A retrospective observational study

Read full text
Authors: Hailong Yu, Hong Yuan, Zhihao Zhang, Xinyuan Zhao, Bin Zheng, Xiaoyu Wang, Yin Hu, Hongwei Wang
Cited by: 1
References: 33

Abstract

To investigate the independent risk factors of significant intraoperative blood loss (SIBL) in cervical spondylotic myelopathy (CSM) patients who receive unilateral expansive open-door cervical laminoplasty (UEOCL) treatment. UEOCL is a representative method for surgically treating CSM, while SIBL (with an IBL ≥ 500 mL) cannot be completely avoided. The 341 patients who received UEOCL for CSM treatment at our hospital from 2013 to 2019 fell into the SIBL group (n = 37) and the non-SIBL group (n = 304). We retrospectively recorded demographic, surgical and radiographic data for the investigation of the independent risk factors related to SIBL. Statistical analysis relied on R software. Univariate and multivariate logistic regression analyses served for more deeply examining the significance of these factors. CSM patients presented an incidence of SIBL of 10.9% (37/341) during UEOCL. According to a multivariate analysis, duration of operation ≥ 150 minutes (OR, 2.598; 95% CI, 1.136-5.942; P = .024), preoperative FIB (OR, 0.480; 95% CI, 0.245-0.941; P = .033) and surgical-level OPLL (OR, 2.668; 95% CI, 1.235-5.765; P = .013) could independently indicate the risk of SIBL. As for patients with SIBL, an obvious increase was not detected in the postoperative drainage (P = .636), the length of stay (P = .392) and the hospitalization cost (P = .389) but it was in the frequency of blood transfusions (P < .001). Duration of operation ≥ 150 minutes, preoperative FIB and surgical-level OPLL were independent risk factors for SIBL. Patients with SIBL had no significant more postoperative drainage, longer length of stay and higher hospitalization costs, but higher frequency of blood transfusion.

Fields of Study & Subjects

Cervical and Thoracic Myelopathy Blood transfusion and management Inflammatory Biomarkers in Disease Prognosis

Publication details

Journal / source
Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
105
Issue
20
Pages
e48869–e48869
Publication date
15 May 2026
Language
EN